Skip to content
PatentBrief

Company Portfolio

Immatics Biotechnologies

43

Portfolio strength

Active portfolio

Patents indexed

3

Year range

2019 – 2024

biotechpharmaceuticalimmunotherapygene_editingoncology

Patent Activity by Year

2019
1
2023
1
2024
1

Key Inventors

Oliver Schoor2Andrea MAHR2Toni Weinschenk2Juliane Sarah WALZ1Daniel Johannes Kowalewski1Hans-Georg Rammensee1Markus Loeffler1Annika NELDE1

All Patents

3

Career timeline

3 patents, 2019–2024

Dot size = forward citations

201920202021202220232024

Hover or tap any dot to see the patent. Larger dots indicate more forward citations — a proxy for downstream influence.

US 10314897·2019

How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer

This patent describes methods to fight various cancers by using a specific protein fragment (peptide LYHDIFSRL) to train a patient's immune cells to recognize and attack tumor cells.

US 12168044·2024

Treating Liver Cancer with Specially Trained Immune Cells

This patent describes a method for treating hepatocellular cancer by giving patients specially activated immune cells that are trained to recognize and kill cancer cells displaying a specific protein fragment.

US 11542303·2023

How a Specific Peptide Boosts the Immune System Against Cancer

This patent describes a specific peptide sequence, KESDGFHRF, combined with immune-boosting substances and a safe delivery method, for use in treating cancer through immunotherapy.

Patent monitoring

Get notified when Immatics Biotechnologies files a new patent

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.